Skip to main content

Navigation group

Type at least 3 characters
1,873 articles

Articles

Original Research

Published on 02 Jun 2023

Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach

in Molecular Diagnostics and Therapeutics

  • Geovanny Genaro Reivan Ortiz
  • Carmen Iulia Ciongradi
  • M. V. N. L. Chaitanya
  • Jayasankar Narayanan
  • Mohamed Mohany
  • Salim S. Al-Rejaie
  • José Luis Arias-Gonzáles
  • Ioan Sârbu
  • Marjan Assefi
  • Shaik Vaseem Akram
Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2023.1189527
  • 4,731 views
  • 3 citations

Original Research

Published on 19 May 2023

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells

in Molecular Diagnostics and Therapeutics

  • Maria Carmen Rodenas
  • Julia Peñas-Martínez
  • Irene Pardo-Sánchez
  • David Zaragoza-Huesca
  • Carmen Ortega-Sabater
  • Jorge Peña-García
  • Salvador Espín
  • Guillermo Ricote
  • Sofía Montenegro
  • Francisco Ayala-De La Peña
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2023.1182925
  • 4,808 views
  • 3 citations